Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Yvonne Kienast"'
Autor:
Amy E. Kirby, Yvonne Kienast, Wanzhe Zhu, Jerusha Barton, Emeli Anderson, Melissa Sizemore, Jan Vinje, Christine L. Moe
Publikováno v:
Viruses, Vol 12, Iss 2, p 179 (2020)
Norovirus is the most common cause of epidemic and endemic acute gastroenteritis. However, national estimates of the infection burden are challenging. This study used a nationally representative serum bank to estimate the seroprevalence to five norov
Externí odkaz:
https://doaj.org/article/fe75e030129a4a629fc3edda843d018c
Autor:
Gergely Solecki, Matthias Osswald, Daniel Weber, Malte Glock, Miriam Ratliff, Hans-Joachim Müller, Oliver Krieter, Yvonne Kienast, Wolfgang Wick, Frank Winkler
Publikováno v:
Cancers, Vol 11, Iss 3, p 314 (2019)
Antiangiogenic strategies have not shown striking antitumor activities in the majority of glioma patients so far. It is unclear which antiangiogenic combination regimen with standard therapy is most effective. Therefore, we compared anti-VEGF-A, anti
Externí odkaz:
https://doaj.org/article/775cb2d1ed174911b4b91aaabe9fedf6
Autor:
Markus Thomas, Yvonne Kienast, Werner Scheuer, Monika Bähner, Klaus Kaluza, Christian Gassner, Frank Herting, Ulrich Brinkmann, Stefan Seeber, Anita Kavlie, Martin Welschof, Stefan Ries, K Michael Weidner, Jörg T Regula, Christian Klein
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e54923 (2013)
There is increasing experimental evidence for an important role of Angiopoietin-2 (Ang-2) in tumor angiogenesis and progression. In addition, Ang-2 is up-regulated in many cancer types and correlated with poor prognosis. To investigate the functional
Externí odkaz:
https://doaj.org/article/bc383949771b43a4a38b519f5fd75a2a
Autor:
Frank Winkler, Jochen Herms, Steffen Burgold, Stefan Grau, Yvonne Kienast, Anca Tirniceru, David Brucker, Louisa von Baumgarten
CCR Translation for This Article from Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d280c2b3b2883e3cef81d6b075b4a05d
https://doi.org/10.1158/1078-0432.22442340
https://doi.org/10.1158/1078-0432.22442340
Autor:
Markus Thomas, Hellmut G. Augustin, Kate Munro, Kay-Gunnar Stubenrauch, Christian Gassner, Laurent Martarello, Huynh Hung The, Sidney Yu, Frank Herting, Dirk Bernicke, Erica Lorenzon, Romi Raemsch, Werner Scheuer, Christian Klein, Yvonne Kienast
PDF file 69K, Ang-2 induced VEGFR-2 upregulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c6c7047fef83903a5f63b8f9d638303
https://doi.org/10.1158/1078-0432.22445409
https://doi.org/10.1158/1078-0432.22445409
Autor:
Markus Thomas, Hellmut G. Augustin, Kate Munro, Kay-Gunnar Stubenrauch, Christian Gassner, Laurent Martarello, Huynh Hung The, Sidney Yu, Frank Herting, Dirk Bernicke, Erica Lorenzon, Romi Raemsch, Werner Scheuer, Christian Klein, Yvonne Kienast
PDF file 138K, Ex vivo mode of action analysis of Ang-2-VEGF-A inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1251f4f980be8b97af8f896f437bee34
https://doi.org/10.1158/1078-0432.22445415
https://doi.org/10.1158/1078-0432.22445415
Autor:
Frank Winkler, Jochen Herms, Steffen Burgold, Stefan Grau, Yvonne Kienast, Anca Tirniceru, David Brucker, Louisa von Baumgarten
Purpose: Bevacizumab targets VEGF-A and has proved beneficial in glioma patients, improving clinical symptoms by the reduction of tumor edema. However, it remains controversial whether or not bevacizumab exerts antitumor effects in addition to (and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57d29fff765fbaf0cd7ab8e1fcbde614
https://doi.org/10.1158/1078-0432.c.6519093
https://doi.org/10.1158/1078-0432.c.6519093
Autor:
Markus Thomas, Hellmut G. Augustin, Kate Munro, Kay-Gunnar Stubenrauch, Christian Gassner, Laurent Martarello, Huynh Hung The, Sidney Yu, Frank Herting, Dirk Bernicke, Erica Lorenzon, Romi Raemsch, Werner Scheuer, Christian Klein, Yvonne Kienast
PDF file 67K, A2V CrossMab treatment inhibits angiogenesis in the VEGF-induced cornea pocket assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c46aff4612ab5ff9931af2c9d2aad43
https://doi.org/10.1158/1078-0432.22445418.v1
https://doi.org/10.1158/1078-0432.22445418.v1
Autor:
Markus Thomas, Hellmut G. Augustin, Kate Munro, Kay-Gunnar Stubenrauch, Christian Gassner, Laurent Martarello, Huynh Hung The, Sidney Yu, Frank Herting, Dirk Bernicke, Erica Lorenzon, Romi Raemsch, Werner Scheuer, Christian Klein, Yvonne Kienast
Purpose: VEGF-A blockade has been clinically validated as a treatment for human cancers. Angiopoietin-2 (Ang-2) expression has been shown to function as a key regulator of tumor angiogenesis and metastasis.Experimental Design: We have applied the rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633a2915093a2b5a7ad1ed7b0be7db7b
https://doi.org/10.1158/1078-0432.c.6520470
https://doi.org/10.1158/1078-0432.c.6520470
Autor:
Markus Thomas, Hellmut G. Augustin, Kate Munro, Kay-Gunnar Stubenrauch, Christian Gassner, Laurent Martarello, Huynh Hung The, Sidney Yu, Frank Herting, Dirk Bernicke, Erica Lorenzon, Romi Raemsch, Werner Scheuer, Christian Klein, Yvonne Kienast
PDF file 108K, Detailed description of experimental procedures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34415a1c8793560c865554b8b745ffc8
https://doi.org/10.1158/1078-0432.22445406.v1
https://doi.org/10.1158/1078-0432.22445406.v1